⌘K

Home/Filings/4/0001516551-24-000102

4//SEC Filing

ARSENAULT KAITLYN 4

Accession 0001516551-24-000102

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 8:32 PM ET

Size

5.7 KB

Accession

0001516551-24-000102

Insider Transaction Report

Form 4

Period: 2024-10-28

Skye Bioscience, Inc.SKYE

ARSENAULT KAITLYN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2024-10-28+125,000→ 125,000 total
Exercise: $5.15Exp: 2034-10-27→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.

Documents

1 file

4
wk-form4_1730334740.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0001877242

Filing Metadata

Form type: 4
Filed: Oct 29, 8:00 PM ET
Accepted: Oct 30, 8:32 PM ET
Size: 5.7 KB

View on SEC.gov